Avi B. Markowitz
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
-
- Renal cell carcinoma treatment 2
- Co-authors
- Catherine M. Broome (1 shared paper)John Gutheil (1 shared paper)David J. Vaughn (1 shared paper)Maha Hussain (1 shared paper)Jae Y. Ro (2 shared papers)Avishay Sella (2 shared papers)David Parkinson (4 shared papers)James L. Abbruzzese (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (2 papers)Cancer Treatment Reviews (1 paper)The Lancet Oncology (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesHong KongCanada
In The Last Decade
Avi B. Markowitz
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Otorhinolaryngology 96
- Oncology 480
- Pulmonary and Respiratory Medicine 334
- Immunology 224
- Surgery 304
Countries citing papers authored by Avi B. Markowitz
This map shows the geographic impact of Avi B. Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi B. Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi B. Markowitz more than expected).
Fields of papers citing papers by Avi B. Markowitz
This network shows the impact of papers produced by Avi B. Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi B. Markowitz. The network helps show where Avi B. Markowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Avi B. Markowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 203 | |
| 2 | 1994 | 178 | |
| 3 | 2002 | 164 | |
| 4 | 2015 | 123 | |
| 5 | 1993 | 110 | |
| 6 | 1993 | 67 | |
| 7 | 1993 | 38 | |
| 8 | 1993 | 32 | |
| 9 | 1992 | 32 | |
| 10 | 2012 | 27 | |
| 11 | 2008 | 26 | |
| 12 | Effect of recombinant human interleukin 4 on human monocyte activity. | 1990 | 23 |
| 13 | 1991 | 22 | |
| 14 | Suppression of chronic myelogenous leukemia colony growth by interleukin-4. | 1993 | 20 |
| 15 | 2008 | 17 | |
| 16 | 1999 | 17 | |
| 17 | 2012 | 13 | |
| 18 | 2007 | 12 | |
| 19 | Sporotrichosis associated with an infected cat. | 1985 | 12 |
| 20 | 2015 | 11 |
About Avi B. Markowitz
Avi B. Markowitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Epidemiology, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Head and Neck Cancer Studies (3 papers), Renal cell carcinoma treatment (2 papers), Renal and related cancers (2 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Otorhinolaryngology (96 citations), Oncology (480 citations), Pulmonary and Respiratory Medicine (334 citations), Immunology (224 citations) and Surgery (304 citations). Avi B. Markowitz has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Catherine M. Broome, John Gutheil, David J. Vaughn, Maha Hussain, Jae Y. Ro, Avishay Sella, David Parkinson, James L. Abbruzzese, Richard I. Fisher and David H. Boldt. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Treatment Reviews, The Lancet Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.